SCHEMBL7375826

SCHEMBL7375826

COc1ccc(CC=O)cc1OC1CCCC1

nearest known ligand 0.57

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 11/20 0.57
RECQL P46063 1/20 0.54
PDE4A P27815 11/20 0.52
PDE4C Q08493 7/20 0.52
PDE4D Q08499 7/20 0.52
POLB P06746 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7325038 0.87 PDE4B (0.57) PDE4BRECQLPDE4APDE4CPDE4D
SCHEMBL7448551 0.86 PDE4A (0.62) PDE4BPDE4APDE4CPDE4D
SCHEMBL7326058 0.85 RECQL (0.51) PDE4BRECQLPDE4APDE4CPDE4D
SCHEMBL7325727 0.85 RECQL (0.51) PDE4BRECQLPDE4APDE4CPDE4D
SCHEMBL7361212 0.85 RECQL (0.51) PDE4BRECQLPDE4APDE4CPDE4D
SCHEMBL7326065 0.85 RECQL (0.51) PDE4BRECQLPDE4APDE4CPDE4D
SCHEMBL3976102 0.83 PDE4B (0.57) PDE4BRECQLPDE4APDE4CPDE4D
SCHEMBL5350500 0.83 PDE4B (0.53) PDE4BPDE4APDE4CPDE4DPOLB
SCHEMBL5350503 0.83 PDE4B (0.53) PDE4BPDE4APDE4CPDE4DPOLB
SCHEMBL7328806 0.82 PDE4B (0.53) PDE4BRECQLPDE4APDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0819122-B1 1,3-DIHYDRO-1-(PHENYLALKYL)-2H-IMIDAZOL-2-ONE DERIVATIVES HAVING PDEIV AND CYTOKINE ACTIVITY JANSSEN PHARMACEUTICA NV (BE) 2002-03-06 EP disclosed
EP-0832071-A1 1,3-DIHYDRO-2H-IMIDAZOL-2-ONE DERIVATIVES HAVING PDE IV AND CYTOKININ INHIBITING ACTIVITY JANSSEN PHARMACEUTICA N.V. (BE) 1998-04-01 EP disclosed
WO-1996031487-A1 1,3-DIHYDRO-2H-IMIDAZOL-2-ONE DERIVATIVES HAVING PDE IV AND CYTOKININ INHIBITING ACTIVITY JANSSEN PHARMACEUTICA N.V. (BE) 1996-10-10 WO disclosed